| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |